Table 1.
Correlations of both PDGF-BB and VEGF-C coexpression with clinicopathological factors in primary human NSCLC
| Factors | P + V+ | P-V- | P1 | P + V - | P2 | P-V+ | P3 | |
|---|---|---|---|---|---|---|---|---|
| Gender |
Male |
35 |
13 |
0.476 |
16 |
0.716 |
14 |
0.847 |
| |
Female |
17 |
4 |
|
5 |
|
5 |
|
| Age |
>60 years |
23 |
11 |
0.047 |
13 |
0.859 |
11 |
0.676 |
| |
≤60 years |
29 |
6 |
|
8 |
|
8 |
|
| Histology |
SQC |
28 |
6 |
0.184 |
6 |
0.539 |
5 |
0.559 |
| |
ADC |
24 |
11 |
|
15 |
|
14 |
|
| Tumor size |
>5 cm |
24 |
3 |
0.037 |
5 |
0.950 |
6 |
0.563 |
| |
≤5 cm |
28 |
14 |
|
16 |
|
13 |
|
| differentiation |
WD, MD |
35 |
17 |
0.017 |
17 |
0.757 |
12 |
0.027 |
| |
PD |
17 |
0 |
|
4 |
|
7 |
|
| TNM stage |
I-IIa |
12 |
8 |
0.113 |
10 |
0.973 |
8 |
0.765 |
| |
IIb-III |
40 |
9 |
|
11 |
|
11 |
|
| Nodal status |
Positive |
29 |
3 |
0.006 |
5 |
0.471 |
7 |
0.362 |
| Negative | 23 | 14 | 14 | 12 |
Note: P1, P value between P + V + and P-V-; P2 , P value between P + V- and P-V-; P3, P value between P-V + and P-V-.
Abbreviations: WD well differentiated, MD moderately differentiated, PD poorly differentiated, ADC adenocarcinoma, SQC squamous cell carcinoma.